{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-028136","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2022-10-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.588263+00:00","generated_at":"2026-06-23T04:20:24.176152+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Bone Biologics prices $5.1M public offering of 3.78M units at $1.35/unit","bullets":["Gross proceeds $5.1M from sale of 3,777,778 units; net proceeds estimated ~$4.454M.","Each unit: 1 common share plus Series A ($1.62), B ($1.35), C ($2.16) warrants, 5-year term.","Series C warrant cashless exercise trigger: 15 days after issuance or $10M common stock volume traded.","Underwriters granted 45-day over-allotment option for up to 566,666 additional shares/warrants.","Closing expected October 12, 2022; WallachBeth Capital acting as sole book-running manager."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-028136","json":"https://secwatch.observer/filing/0001493152-22-028136.json","markdown":"https://secwatch.observer/filing/0001493152-22-028136.md","text":"https://secwatch.observer/filing/0001493152-22-028136.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222028136/0001493152-22-028136-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315222028136/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T04:20:24.176152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}